We Give Shareholders a Voice

Amedisys Inc. Information Request Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of Amedisys by Option Care Health, Inc. (“Option Care”). As a result of the merger, Amedisys stockholders are anticipated to receive only 3.0213 shares of Option Care common stock, at the time indicating a value of $97.38 per share. On June 5, 2023, UnitedHealth Group made an offer to purchase Amedisys for $100.00 per share in cash, but the Company’s agreement with Option Care limits the Board’s ability to accept this new offer. The Amedisys merger investigation concerns whether the Board of Amedisys has harmed stockholders by agreeing to enter into the transaction with Option Care and whether all material facts have been properly disclosed to stockholders.

To receive more information, please fill out the form.

Enter Your Details Below

This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

Review our Privacy Policy